Vanguard Capital Management’s MAIA Biotechnology MAIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.85M Hold
2,413,270
– – ﹤0.01% 3256
2026
Q2
$3.48M Buy
2,413,270
+339,225
+16% +$451K ﹤0.01% 3241
2026
Q1
$2.9M Buy
+2,074,045
New +$3.82M ﹤0.01% 3244

Other funds holding MAIA

Vanguard Capital Management's MAIA Position: Q3 2026 in Review

Vanguard Capital Management held its MAIA Biotechnology (MAIA) position steady in Q3 2026 at 2,413,270 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3256.

Vanguard Capital Management first reported a position in MAIA in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.48M in Q2 2026. 44 funds tracked by Wall St. Rank hold MAIA as of Q3 2026.

  • Vanguard Capital Management held 2,413,270 shares of MAIA Biotechnology worth $2.85M as of Q3 2026.
  • Vanguard Capital Management left its MAIA Biotechnology share count unchanged in Q3 2026.
  • MAIA Biotechnology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3256 holding.
  • Vanguard Capital Management first reported a position in MAIA Biotechnology in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's MAIA Biotechnology position peaked at $3.48M in Q2 2026.
  • 44 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.